Cyclo Therapeutics, Inc. (CYTH)

Cyclo Therapeutics Revenue

Cyclo Therapeutics had revenue of $233.77K in the quarter ending September 30, 2024, a decrease of -52.82%. This brings the company's total for the last twelve months to $870.73K, down -8.52% year-over-year. In the year 2023, Cyclo Therapeutics had annual revenue of $1.08M, down -21.76%.

• Revenue (ttm): $870.73K
• Revenue Growth: -8.52%
• P/S Ratio: 22.38
• Revenue / Employee: $108,841
• Employees: 8
• Market Cap: 20.73M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.08M	-299.36K	-21.76%
Dec 31, 2022	1.38M	-210.00K	-13.24%
Dec 31, 2021	1.59M	682.38K	75.54%
Dec 31, 2020	903.38K	-103.82K	-10.31%
Dec 31, 2019	1.01M	-4.28K	-0.42%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error